Pharmaron to acquire Allergan from AbbVie for $119m.

Pharmaron, a service provider for the life sciences industry, agreed to acquire Allergan, an Irish pharmaceutical company, from AbbVie, a producer of pharmaceutical drugs, for $119m. “We are pleased to have the ABL site join the Pharmaron Group. We have been impressed with the CGT focused process R&D and complex biologic manufacturing capabilities of the ABL site, as well as the abilities that the highly experienced scientific, technical and managerial teams have demonstrated. The addition of this platform to Pharmaron will further strengthen our CGT services platform and allow us to better serve our partners’ needs in these exciting and emerging therapies. We are committed to further expanding capabilities and capacities at the Liverpool site to meet growing unmet demand. This transaction demonstrates our commitment to becoming a global leader in drug R&D services across multiple therapeutic modalitiesm,” Boliang Lou, Pharmaron Chairman and CEO.